دورية أكاديمية
Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior.
| العنوان: | Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior. |
|---|---|
| المؤلفون: | Peyriere H; INSERM U1175/IRD UMI 233, Montpellier University, Montpellier, France.; Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, CHU Montpellier, Montpellier, France., Jacquet JM; Department of Addictology, Nimes University Hospital, Nimes, France., Peries M; Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, CHU Montpellier, Montpellier, France., Tribout V; Sexual Transmitted Infections Center, Montpellier University, Montpellier, France., Broche B; Sexual Transmitted Infections Center, Nimes, France., Mauboussin JM; Infectious Diseases Department, Nimes University Hospital, Nimes, France., Makinson A; INSERM U1175/IRD UMI 233, Montpellier University, Montpellier, France.; Infectious Diseases Department, Montpellier University Hospital, Montpellier, France., Perrollaz C; Sexual Transmitted Infections Center, Montpellier University, Montpellier, France., Ferreyra M; Sexual Transmitted Infections Center, Perpignan, France., Rouanet I; Infectious Diseases Department, Nimes University Hospital, Nimes, France., Montoya-Ferrer A; Infectious Diseases Department, Montpellier University Hospital, Montpellier, France., El-Majjaoui S; Sexual Transmitted Infections Center, Nimes, France., Corriol-Bonifas F; Infectious Diseases Department, Alès Hospital, Alès, France., Fraisse T; Infectious Diseases Department, Alès Hospital, Alès, France., Grau F; Sexual Transmitted Infections Center, Nimes, France., Laureillard D; Infectious Diseases Department, Nimes University Hospital, Nimes, France., Nagot N; Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, CHU Montpellier, Montpellier, France., Reynes J; INSERM U1175/IRD UMI 233, Montpellier University, Montpellier, France.; Infectious Diseases Department, Montpellier University Hospital, Montpellier, France., Donnadieu-Rigole H; Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, CHU Montpellier, Montpellier, France.; Department of Addictology, Montpellier University Hospital, Montpellier, France. |
| المصدر: | Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2023 Jun; Vol. 37 (3), pp. 639-649. Date of Electronic Publication: 2022 Dec 01. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Blackwell Science Country of Publication: England NLM ID: 8710411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-8206 (Electronic) Linking ISSN: 07673981 NLM ISO Abbreviation: Fundam Clin Pharmacol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2001->: Oxford : Blackwell Science Original Publication: Paris ; New York : Elsevier, c1987- |
| مواضيع طبية MeSH: | HIV Infections*/diagnosis , HIV Infections*/prevention & control , Pre-Exposure Prophylaxis* , Behavior, Addictive* , Substance-Related Disorders*/prevention & control, Adult ; Male ; Humans ; Homosexuality, Male/psychology ; Mood Disorders/prevention & control ; Cross-Sectional Studies |
| مستخلص: | The assessment of mood disorders and addiction linked to the practice of chemsex is of interest given the psychoactive substances used. The aim of this study was to assess risky sexual and addictive behavior to chemsex and related anxiety/depression symptoms in individuals receiving HIV pre-exposure prophylaxis (PrEP). In this cross-sectional study, all adults presenting for PrEP renewal at French sexual health centers were enrolled from January 2018 to March 2019. Participants completed a questionnaire on chemsex (i.e., the use of psychoactive substances before/during sex), including adapted Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) to chemsex addiction (questions of ASSIST were modified to focus on chemsex). Anxiety/depression was assessed with the Hospital Anxiety and Depression Scale. In the last 3 months before enrollment, 39.8% (94/236) of participants reported chemsex. The main psychoactive substances consumed during chemsex were cathinones (74.6%), gamma-hydroxybutyrate (66.3%), and other psychostimulants (60%). The median score of the chemsex-focused ASSIST was 8 [IQR (© 2022 Société Française de Pharmacologie et de Thérapeutique. Published by John Wiley & Sons Ltd.) |
| References: | Edmundson C, Heinsbroek E, Glass R, et al. Sexualised drug use in the United Kingdom (UK): a review of the literature. Int J Drug Policy. 2018;55:131-148. doi:10.1016/j.drugpo.2018.02.002. Fisher DG, Reynolds GL, Ware MR, Napper LE. Methamphetamine and Viagra use: relationship to sexual risk behaviors. Arch Sex Behav. 2011;40(2):273-279. doi:10.1007/s10508-009-9495-5. Melendez-Torres GJ, Bourne A, Hickson F, Reid D, Weatherburn P. Correlates and subgroups of injecting drug use in UK gay and bisexual men: findings from the 2014 gay men's sex survey. Drug Alcohol Depend. 2018;187:292-295. doi:10.1016/j.drugalcdep.2018.03.014. Benotsch EG, Lance SP, Nettles CD, Koester S. Attitudes toward methamphetamine use and HIV risk behavior in men who have sex with men. Am J Addict. 2012;21:S35-S42. doi:10.1111/j.1521-0391.2012.00294.x. Bui H, Zablotska-Manos I, Hammoud M, et al. Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: results from the FLUX study. Int J Drug Policy. 2018;55:222-230. doi:10.1016/j.drugpo.2018.01.018. Maxwell S, Shahmanesh M, Gafos M. Chemsex behaviors among men who have sex with men: a systematic review of the literature. Int J Drug Policy. 2019;63:74-89. doi:10.1016/j.drugpo.2018.11.014. Donnadieu-Rigole H, Peyrière H, Benyamina A, Karila L. Complications related to sexualized drug use: what can we learn from literature? Front Neurosci. 2020;14:548704. doi:10.3389/fnins.2020.548704. Dolengevich-Segal H, Gonzalez-Baeza A, Valencia J, et al. Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): data from the U-SEX GESIDA 9416 study. PLoS One. 2019;14(12):e0220272. doi:10.1371/journal.pone.0220272. eCollection 2019. Lafortune D, Blais M, Miller G, Dion L, Lalonde F, Dargis L. Psychological and interpersonal factors associated with sexualized drug use among men who have sex with men: a mixed-Methods systematic review. Arch Sex Behav. 2021;50(2):427-460. doi:10.1007/s10508-020-01741-8. Íncera-Fernández D, Gámez-Guadix M, Moreno-Guillén S. Mental health symptoms associated with sexualized drug use (chemsex) among men who have sex with men: a systematic review. Int J Environ Res Public Health. 2021;18(24):13299. doi:10.3390/ijerph182413299. Batisse A, Eiden C, Deheul S, Monzon E, Djezzar S, Peyrière H. Chemsex practice in France: An update in addictovigilance data. Fundam Clin Pharmacol. 2021;36(2):397-404. doi:10.1111/fcp.12725. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-2599. doi:10.1056/NEJMoa1011205. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: WHO; 2015. https://apps.who.int/iris/bitstream/handle/10665/186275/9789241509565eng.pdf?sequence=1. Roux P, Fressard L, Suzan-Monti M, et al. Is on-demand HIV pre-exposure prophylaxis a suitable tool for men who have sex with men who practice chemsex? Results from a substudy of the ANRS-IPERGAY trial. J Acquir Immune Defic Syndr. 2018;79(2):e69-e75. doi:10.1097/QAI.0000000000001781. Hegazi A, Lee MJ, Whittaker W, et al. Chemsex and the city: sexualised substance use in gay bisexual and other men who have sex with men attending sexual health clinics. Int J STD AIDS. 2017;28(4):362-366. doi:10.1177/0956462416651229. Pakianathan M, Whittaker W, Lee MJ, et al. Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics. HIV Med. 2018;19(7):485-490. doi:10.1111/hiv.12629. Hanum N, Cambiano V, Sewell J, et al. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. Lancet Public Health. 2020;5(9):e501-e511. doi:10.1016/S2468-2667(20)30186-9. Humeniuk R, Ali R, Babor T, et al. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction. 2012;107(5):957-966. doi:10.1111/j.1360-0443.2011.03740.x. Humeniuk R, Ali R, Babor TF, et al. Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST). Addiction. 2008;103(6):1039-1047. doi:10.1111/j.1360-0443.2007.02114.x. Dawson Rose C, Cuca YP, Kamitani E, et al. Using interactive web-based screening, brief intervention and referral to treatment in an urban, safety-net HIV clinic. AIDS Behav. 2015;19(Suppl 2(0 2)):186-193. Jacquet JM, Donnadieu-Rigole H, Peries M, et al. MesConsos study group name. Implementing screening, brief intervention and referral to treatment in a French cohort of people living with HIV: a pilot study. HIV Med. 2019;20(4):286-290. doi:10.1111/hiv.12709. http://www.who.int/substance_abuse/terminology/who_ladt/fr/. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. doi:10.1111/j.1600-0447.1983.tb09716.x. Glynn RW, Byrne N, O'Dea S, et al. Chemsex, risk behaviors and sexually transmitted infections among men who have sex with men in Dublin, Ireland. Int J Drug Policy. 2018;52:9-15. doi:10.1016/j.drugpo.2017.10.008. Sewell J, Miltz A, Lampe FC, et al. Poly drug use, chemsex drug use, and associations with sexual risk behavior in HIV-negative men who have sex with men attending sexual health clinics. Int J Drug Policy. 2017;43:33-43. doi:10.1016/j.drugpo.2017.01.001. Drückler S, Van Rooijen MS, de Vries HJC. Chemsex among men who have sex with men: a sexualized drug use survey among clients of the sexually transmitted infection outpatient clinic and users of a gay dating app in Amsterdam, the Netherlands. Sex Transm Dis. 2018;45(5):325-331. doi:10.1097/OLQ.0000000000000753. Pufall EL, Kall M, Shahmanesh M, et al. Sexualized drug use (‘chemsex’) and high-risk sexual behaviours in HIV-positive men who have sex with men study group. HIV Med. 2018;19(4):261-270. doi:10.1111/hiv.12574. Velter A, Sauvage C, Saboni L, et al. Estimation de la prévalence du VIH chez les hommes ayant des relations sexuelles avec des hommes fréquentant les lieux de convivialité gay de cinq villes françaises - PREVAGAY 2015. Bull Epidémiol Hebd 2017; 18: 347-354. http://invs.santepubliquefrance.fr/beh/2017/18/2017_18_1.html. O'Halloran C, Rice B, White E, et al. Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants. Int J Drug Policy. 2019;74:246-254. doi:10.1016/j.drugpo.2019.10.007. Traeger MW, Cornelisse VJ, Asselin J, et al. PrEPX study team association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection. Jama. 2019;321(14):1380-1390. doi:10.1001/jama.2019.2947. Tomkins A, Ahmad S, Cannon L, et al. Prevalence of recreational drug use reported by men who have sex with men attending sexual health clinics in Manchester, UK. Int J STD AIDS. 2018;29:350-356. Bourne A. The chemsex study: Drug use in sexual settings among gay and bisexual men in Lambeth. Sigma Research: Southwark & Lewisham; 2014. Tomkins A, George R, Kliner M. Sexualised drug taking among men who have sex with men: a systematic review. Perspect Public Health. 2019;139(1):23-33. doi:10.1177/1757913918778872. Karila L, Megarbane B, Cottencin O, Lejoyeux M. Synthetic cathinones: a new public health problem. Curr Neuropharmacol. 2015;13(1):12-20. doi:10.2174/1570159X13666141210224137. Wojcieszak J, Andrzejczak D, Szymańska B, Zawilska JB. Induction of immediate early genes expression in the mouse striatum following acute administration of synthetic cathinones. Pharmacol Rep. 2019;71(6):977-982. doi:10.1016/j.pharep.2019.05.011. Prestage G, Hammoud M, Jin F, Degenhardt L, Bourne A, Maher L. Mental health, drug use and sexual risk behavior among gay and bisexual men. Int J Drug Policy. 2018;55:169-179. doi:10.1016/j.drugpo.2018.01.020. Miltz A, Lampe F, McCormack S, et al. Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxis. BMJ Open. 2019;9(12):e031085. doi:10.1136/bmjopen-2019-031085. Trouiller P, Velter A, Saboni L, et al. Injecting drug use during sex (known as "slamming") among men who have sex with men: results from a time-location sampling survey conducted in five cities, France. Int J Drug Policy. 2020;79:102703. doi:10.1016/j.drugpo.2020.102703. Sewell J, Cambiano V, Speakman A, et al. Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: findings from the AURAH2 study. Int J Drug Policy. 2019;68:54-61. doi:10.1016/j.drugpo.2019.03.021. |
| فهرسة مساهمة: | Keywords: HIV pre-exposure prophylaxis; chemsex; chemsex addiction; cross-sectional study; mood disorders |
| تواريخ الأحداث: | Date Created: 20221120 Date Completed: 20230512 Latest Revision: 20230512 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1111/fcp.12854 |
| PMID: | 36403123 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1472-8206 |
|---|---|
| DOI: | 10.1111/fcp.12854 |